Physician profile
James Reidy
NPI 1174551014
$3,241.37
in general payments reported to CMS, 2019-2025
9 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $131 · 2021: $523 · 2022: $42.44 · 2023: $139 · 2024: $1,943 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,274 · Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,274.36 |
| Food and Beverage | $911.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,832.62 | 2023-2025 | Inspire |
| Stryker Corporation | $620.80 | 2019-2024 | Scopis Ent, Clarifix Cryotherapy Device |
| Medtronic, INC. | $530.90 | 2021-2025 | Nuvent, Propel |
| Medtronic USA, INC. | $74.14 | 2020 | |
| Genzyme Corporation | $59.50 | 2024 | |
| Aerin Medical INC. | $43.12 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $34.76 | 2024 | Dupixent |
| Karl Storz Endoscopy-America | $26.61 | 2021 | |
| Acclarent, INC | $18.92 | 2023 | Relieva Spinplus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Reidy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.